SPERM Clinical Trial
Official title:
Effect of Dietary DHA Supplementation on Sperm Quality.
The aim of this study is evaluated the effect of dietetic supplementation with DHA on human sperm quality, antioxidant capacity and sperm DNA damage.
Status | Completed |
Enrollment | 120 |
Est. completion date | March 2011 |
Est. primary completion date | December 2010 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Diagnosis of male factor. Exclusion Criteria: - Metabolic and genetic diseases. - Oncological patients. - Patients with anticoagulants treatment. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Spain | Instituto Valenciano de infertilidad | Murcia |
Lead Sponsor | Collaborator |
---|---|
Instituto Valenciano de Infertilidad, IVI VALENCIA | University of Barcelona |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | sperm concentration | million of spermatozoa per milimitre | 5 weeks | No |
Primary | Sperm motility | Percentage of motile sperm. | 5 weeks | No |
Primary | Sperm morphology | Percentage of sperm with normal morphology | 5 weeks | No |
Primary | Total capacity antioxidant | Total antioxidant capacity (TAC)is a colorimetric assay that measure the combined antioxidant activities of all its non enzymatic constituents in seminal plasma. | 5 weeks | No |
Primary | Sperm DNA damage. | DNA fragmentation analysis was evaluated by TUNEL test and measured by flow cytometry | 5 weeks | No |
Primary | Fatty acids measure. | Fatty acid analysis in seminal plasma and spermatozoa were evaluated by gas chromatography.The percentage of each fatty acid class was expressed as percentage of total fatty acids. | 5 weeks | No |
Secondary | Sperm in ejaculate | Million of spermatozoa in eyaculate. | 5 weeks | No |
Secondary | Volume of ejaculate. | Eyaculated milliliters. | 5 weeks | No |
Secondary | Sperm viability | Porcentage of sperm whitout membrane damage | 5 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06172504 -
Ejaculation Frequency and Semen Parameters
|
||
Completed |
NCT02422108 -
TNFSF11 Inhibition and Fertility: a Prospective Study
|
Phase 2 | |
Withdrawn |
NCT02431000 -
Male Fertility and Sperm Cryopreservation
|
||
Withdrawn |
NCT02869425 -
To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS
|
Phase 3 | |
Recruiting |
NCT06243926 -
Sperm Selection by Rheotaxis and Thermotaxis in In-Situ Handmade Microfluidics of Fluidic Walls in the Same ICSI Plate
|
||
Completed |
NCT03153436 -
The Effect of In-vitro Myoinositol Supplementation of Human Sperm on the Outcome of Cryopreservation
|
Phase 1/Phase 2 | |
Recruiting |
NCT05508217 -
Impact of Telomere Biology and Sperm DNA Fragmentation on Embryonic Development
|